Response to "Letter regarding Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy".

Radiother Oncol. 2024 Jan;190:109961. doi: 10.1016/j.radonc.2023.109961. Epub 2023 Oct 21.

Peters N(1), Taasti VT(2), Ackermann B(3), Bolsi A(4), Dahlgren CV(5), Ellerbrock M(3), Fracchiolla F(6), Gomà C(7), Góra J(8), Lopes PC(9), Rinaldi I(10), Salvo K(11), Tarp IS(12), Vai A(13), Bortfeld T(14), Lomax A(4), Richter C(15), Wohlfahrt P(14).

Author information:

(1)OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA. Electronic address: nilspetersmp@gmail.com. (2)Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands. Electronic address: vicki.taasti@maastro.nl. (3)Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. (4)Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland. (5)The Skandion Clinic, Uppsala, Sweden. (6)Azienda Provinciale per i Servizi Sanitari (APSS) Protontherapy Department, Trento, Italy. (7)Department of Radiation Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. (8)MedAustron Ion Therapy Center, Wiener Neustadt, Austria. (9)HollandPTC, Delft, the Netherlands. (10)Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands. (11)AZ Sint-Maarten, Department of Radiotherapy, Mechelen, Belgium. (12)Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus, Denmark. (13)Radiotherapy Department, Center for National Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy. (14)Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA. (15)OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.